Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy selections remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy